维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Major RE"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The potential for ambulation by severely handicapped cerebral palsy patients显示文摘	Major RE Farmer SE	1996	J International Society for Prosthetics and Orthotics1996，20，2：	1
2	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid显示文摘	Coleman RE Major P Lipton A	2005	J Clin Oncol2005，23，22：	1
3	The changing role of extraction in preparation of solid samples显示文摘	Majors RE	1996	LC-GC Intl1996，9，10：	1
4	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid显示文摘	Coleman RE Major P Lipton A	2005	J Clin Oncol2005，23，11：	1
5	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid显示文摘	Coleman RE Major P Lipton A	2005	J Clin Oncol2005，23，22：	1
6	D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach 显示文摘	Williams RE Major H Lock EA	2005	Toxicol2005，207，2：	1
7	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid显示文摘	Coleman RE Major P Lipton A	2005	J Clin Oncol2005，23，：	1
8	D-Serine-induced nephrotoxicity:aHPLC-TOF/MS-based metabonomics approach显示文摘	Williams RE Major H Lock EA	2005	Toxicology2005，207，2：	1
9	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid显示文摘	Coleman RE Major P L ipton A	2005	J ClinOnco l2005，23，5：	1
10	D-Serine-induced nephrotoxicity:a HPLC-TOF/MS-based metabonomics approach显示文摘	Williams RE Major H Lock EA	2005	Toxicology2005，207，：	1
11	Zoledronic acid hyperca of the in the treatment of lcemia of malignancy: results international clinical development Oncol, 2001, 28 (2 program显示文摘	Major PP Coleman RE	2001	Senub Suppl2001，6，：	1
12	Predictive value ofbone resorption and formation markers in cancer patientswith bone metastases receiving the bisphosphonate zole-dronic acid显示文摘	Coleman RE Major P?Lipton A	2005	J Clin Oncol2005，23，22：	1
13	The greening of the chromatography laboratory显示文摘	MAJORS RE RAYNIE D	2011	LC GC North America2011，29，2：	1
14	D-Serine-induced nephrotoxicity:a HPLC-TOF/MS-based metabonomics approach显示文摘	Williams RE Major H Lock EA	2005	Toxicology2005，207，2：	1
15	Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program显示文摘	Major PP Coleman RE	2001	Semin Oncol2001，28，26：	1
16	Phase collapse in reversed -phase liquid chromatography 显示文摘	Przybyciel M Majors RE	2002	LC GC North America2002，20，6：	1
17	Predictive value of bone resorption and formation markers in cancer patients with bone me- tastases receiving the bisphosphonate zoledronic acid 显示文摘	Coleman RE Major P Lipton A	2005	J Clin Oncol2005，23，：	1
18	Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid 显示文摘	Coleman RE Major P Lipton A	2005	JCO2005，23，22：	1
19	Long - term skeletal changes with rapid maxillary expansion: a systematic review显示文摘	MO Lagrav~re PW Major C Flores - Mir	2010	Angle Orthodontist2010，27，17：	1
20	Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program显示文摘	Major PP Coleman RE	2001	Semin Oncol2001，28，26：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示